Riverstone Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.11M | Buy |
3,070
+121
| +4% | +$41.4K | 0.46% | 25 |
|
|
2026
Q1 | $1.04M | Buy |
2,949
+115
| +4% | +$41K | 0.51% | 24 |
|
|
2025
Q4 | $928K | Buy |
2,834
+108
| +4% | +$34.3K | 0.44% | 25 |
|
|
2025
Q3 | $769K | Hold |
2,726
| – | – | 0.38% | 24 |
|
|
2025
Q2 | $761K | Hold |
2,726
| – | – | 0.41% | 23 |
|
|
2025
Q1 | $849K | Sell |
2,726
-20
| -0.7% | -$5.91K | 0.51% | 22 |
|
|
2024
Q4 | $716K | Hold |
2,746
| – | – | 0.41% | 25 |
|
|
2024
Q3 | $885K | Hold |
2,746
| – | – | 0.51% | 23 |
|
|
2024
Q2 | $858K | Hold |
2,746
| – | – | 0.53% | 23 |
|
|
2024
Q1 | $781K | Hold |
2,746
| – | – | 0.47% | 25 |
|
|
2023
Q4 | $791K | Hold |
2,746
| – | – | 0.51% | 25 |
|
|
2023
Q3 | $738K | Buy |
2,746
+15
| +0.5% | +$3.74K | 0.51% | 24 |
|
|
2023
Q2 | $606K | Sell |
2,731
-6
| -0.2% | -$1.39K | 0.37% | 31 |
|
|
2023
Q1 | $662K | Hold |
2,737
| – | – | 0.42% | 29 |
|
|
2022
Q4 | $719K | Sell |
2,737
-1,560
| -36% | -$418K | 0.5% | 24 |
|
|
2022
Q3 | $969K | Sell |
4,297
-20
| -0.5% | -$4.85K | 0.62% | 26 |
|
|
2022
Q2 | $1.05M | Hold |
4,317
| – | – | 0.66% | 23 |
|
|
2022
Q1 | $1.04M | Buy |
4,317
+323
| +8% | +$74.2K | 0.54% | 23 |
|
|
2021
Q4 | $899K | Buy |
3,994
+122
| +3% | +$25.7K | 0.4% | 24 |
|
|
2021
Q3 | $823K | Hold |
3,872
| – | – | 0.38% | 23 |
|
|
2021
Q2 | $944K | Sell |
3,872
-46
| -1% | -$11.3K | 0.45% | 24 |
|
|
2021
Q1 | $975K | Hold |
3,918
| – | – | 0.51% | 23 |
|
|
2020
Q4 | $901K | Hold |
3,918
| – | – | 0.5% | 24 |
|
|
2020
Q3 | $996K | Hold |
3,918
| – | – | 0.66% | 21 |
|
|
2020
Q2 | $924K | Sell |
3,918
-50
| -1% | -$11.4K | 0.69% | 23 |
|
|
2020
Q1 | $804K | Hold |
3,968
| – | – | 0.81% | 21 |
|
|
2019
Q4 | $957K | Hold |
3,968
| – | – | 0.71% | 23 |
|
|
2019
Q3 | $768K | Hold |
3,968
| – | – | 0.59% | 25 |
|
|
2019
Q2 | $731K | Sell |
3,968
-133
| -3% | -$23.8K | 0.57% | 26 |
|
|
2019
Q1 | $779K | Hold |
4,101
| – | – | 0.66% | 25 |
|
|
2018
Q4 | $798K | Buy |
+4,101
| New | +$800K | 0.8% | 24 |
|
Other funds holding AMGN
Riverstone Advisors's AMGN Position: Q2 2026 in Review
Riverstone Advisors increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $41.4K and bringing the position to 3,070 shares worth $1.11M. The position accounts for 0.46% of the portfolio, ranked #25.
Riverstone Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Riverstone Advisors held 3,070 shares of Amgen worth $1.11M as of Q2 2026.
- Riverstone Advisors bought 121 Amgen shares in Q2 2026, an estimated $41.4K.
- Amgen made up 0.46% of Riverstone Advisors's portfolio in Q2 2026, its #25 holding.
- Riverstone Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Riverstone Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.